Chimeric Stem Cell Tech: Multi-Industry Innovation

The original patent focused on treating inflammation in chimeric animals after birth. However, the chimeric technology has vast untapped potential. The present invention addresses the limitation of the original patent by exploring new industries and use cases, including agricultural livestock, crop yield improvement, skin condition treatment, personalized medicine, and tissue regeneration.

The novelty of the present invention lies in its expansion of chimeric technology into new fields, leveraging the core principles to address distinct challenges. The inventive step is the recognition of the broad applicability of chimeric technology and the development of specific solutions for various industries.

Alternative embodiments may include using different types of pluripotent cells, varying the administration methods of anti-inflammatory agents, or integrating chimeric technology with existing agricultural or medical practices. Variations may also involve adapting the technology for use in different species or developing new compositions for treating various diseases.

The present invention has significant commercial potential across multiple industries. In agriculture, the technology can improve crop yields and reduce livestock losses. In medicine, it can lead to breakthroughs in personalized treatment and tissue regeneration. The market for these applications is vast, with potential customers including agricultural companies, pharmaceutical firms, and medical research institutions.